Jonathan Freve serves as Executive at Spring Bank Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Jonathan Freve has executed 9 insider transactions totaling $104.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 3, 2021 involved purchasing 4,000 shares valued at $10.0K.
Jonathan Freve currently holds 12,000 shares of Spring Bank Pharmaceuticals, Inc. (SBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Freve has been a net buyer of SBPH stock. They have purchased $104.1K and sold $0 worth of shares.
Jonathan Freve's most recent insider trade was on Dec 3, 2021, when they purchased 4,000 shares at $2.49 per share.
Get notified when new Form 4 filings are submitted
| $3.40 |
| Discretionary |
| Aug 18, 2021 | GLTO | $11.8K | Purchase | 3,000 | $3.92 | Discretionary |
| Jun 23, 2021 | GLTO | $9.5K | Purchase | 2,000 | $4.74 | Discretionary |
| Nov 14, 2019 | SBPH | $15.2K | Purchase | 5,000 | $3.04 | Discretionary |
| May 29, 2019 | SBPH | $27.0K | Purchase | 5,000 | $5.40 | Discretionary |
| Nov 23, 2016 | SBPH | $50.0K | Award | 5,482 | $9.12 | Discretionary |
| Aug 23, 2016 | SBPH | $10.7K | Purchase | 1,000 | $10.74 | Discretionary |
| Aug 4, 2016 | SBPH | $9.8K | Purchase | 1,000 | $9.75 | Discretionary |